HAEMATO AG
HAEMATO AG, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative therapies for patients with rare diseases and complex health conditions. Founded in 1993, the company has established a strong presence across Europe, focusing on key operational regions such as Germany and other EU countries. With a commitment to enhancing patient care, HAEMATO AG offers a diverse portfolio of products, including specialty pharmaceuticals and biosimilars, which are distinguished by their high quality and efficacy. The company has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector, known for its dedication to research and development. HAEMATO AG continues to make strides in the market, contributing to advancements in treatment options and improving the lives of patients worldwide.
DitchCarbon Score
How does HAEMATO AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HAEMATO AG's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HAEMATO AG's reported carbon emissions
HAEMATO AG currently does not have publicly available carbon emissions data or specific reduction targets outlined in their climate commitments. Without concrete figures or defined initiatives, it is challenging to assess their carbon footprint or climate strategy. However, the company may still be engaged in industry-standard practices aimed at reducing environmental impact, although specific details are not provided. As the climate landscape evolves, it is essential for companies like HAEMATO AG to establish measurable targets and transparent reporting to contribute effectively to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HAEMATO AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
